Gary Li
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Virology top 10%
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 3
- Co-authors
- Melanie A. Krook (1 shared paper)Hui‐Zi Chen (1 shared paper)Sameek Roychowdhury (1 shared paper)Gabrielle Ernst (1 shared paper)Max Wilberding (1 shared paper)Julie W. Reeser (1 shared paper)Kenneth H. Grabstein (4 shared papers)Pauline A. Bariola (2 shared papers)
- Journals
- Oncotarget (2 papers)Bioconjugate Chemistry (2 papers)Journal of Immunological Methods (1 paper)Nature Reviews Materials (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Gary Li
19 papers receiving 944 citations
Gary Li's Hit Papers
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 95
- Virology 60
- Immunology 179
- Oncology 196
- Radiology, Nuclear Medicine and Imaging 144
Countries citing papers authored by Gary Li
This map shows the geographic impact of Gary Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Li more than expected).
Fields of papers citing papers by Gary Li
This network shows the impact of papers produced by Gary Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Li. The network helps show where Gary Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance Hit paper breakdown → | 2020 | 259 |
| 2 | A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines Hit paper breakdown → | 2023 | 150 |
| 3 | 2015 | 129 | |
| 4 | 2019 | 75 | |
| 5 | 2011 | 72 | |
| 6 | 2020 | 49 | |
| 7 | 2015 | 42 | |
| 8 | 2023 | 35 | |
| 9 | 2024 | 34 | |
| 10 | 2018 | 32 | |
| 11 | 2017 | 20 | |
| 12 | 2014 | 19 | |
| 13 | 2015 | 16 | |
| 14 | 2023 | 16 | |
| 15 | 2015 | 10 | |
| 16 | 2024 | 7 | |
| 17 | 2020 | 4 | |
| 18 | 2019 | 3 | |
| 19 | 2020 | 1 | |
| 20 | 2020 | 0 |
About Gary Li
Gary Li is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmaceutical Science, Oncology, Immunology and Molecular Biology, having authored 20 papers that have together received 973 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Fibroblast Growth Factor Research (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Lung Cancer Research Studies (2 papers), Connective tissue disorders research (2 papers), Peptidase Inhibition and Analysis (2 papers), RNA Interference and Gene Delivery (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Virology (60 citations), Immunology (179 citations), Oncology (196 citations) and Radiology, Nuclear Medicine and Imaging (144 citations). Gary Li has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Melanie A. Krook, Hui‐Zi Chen, Sameek Roychowdhury, Gabrielle Ernst, Max Wilberding, Julie W. Reeser, Kenneth H. Grabstein, Pauline A. Bariola, Kurt D. Shanebeck and Patrick C. Fagan. Their work appears in journals such as Oncotarget, Bioconjugate Chemistry, Journal of Immunological Methods, Nature Reviews Materials and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.